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Abstract
Enhanced understanding of differential gene expression and biological pathways associated with distinct phases of
intramembranous bone regeneration following femoral marrow ablation surgery will improve future advancements
regarding osseointegration of joint replacement implants, biomaterials design, and bone tissue engineering. A rat femoral
marrow ablation model was performed and genome-wide microarray data were obtained from samples at 1, 3, 5, 7, 10, 14,
28, and 56 days post-ablation, with intact bones serving as controls at Day 0. Bayesian model-based clustering produced
eight distinct groups amongst 9,062 significant gene probe sets based on similar temporal expression profiles, which were
further categorized into three major temporal classes of increased, variable, and decreased expression. Osteoblastic- and
osteoclastic-associated genes were found to be significantly expressed within the increased expression groups.
Chondrogenesis was not detected histologically. Adipogenic marker genes were found within variable/decreased
expression groups, emphasizing that adipogenesis was inhibited during osteogenesis. Differential biological processes and
pathways associated with each major temporal group were identified, and significantly expressed genes involved were
visually represented by heat maps. It was determined that the increased expression group exclusively contains genes
involved in pathways for matrix metalloproteinases (MMPs), Wnt signaling, TGF-b signaling, and inflammatory pathways.
Only the variable expression group contains genes associated with glycolysis and gluconeogenesis, the notch signaling
pathway, natural killer cell mediated cytotoxicity, and the B cell receptor signaling pathway. The decreased group
exclusively consists of genes involved in heme biosynthesis, the p53 signaling pathway, and the hematopoietic cell lineage.
Significant biological pathways and transcription factors expressed at each time point post-ablation were also identified.
These data present the first temporal gene expression profiling analysis of the rat genome during intramembranous bone
regeneration induced by femoral marrow ablation.
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Introduction
Bone is a dynamic organ that undergoes continuous remodeling
by controlled cycles of bone resorption and bone formation, which
are balanced to preserve bone mass. In the case of common
metabolic bone disorders, such as osteoporosis, reduction in skeletal
mass is caused by an imbalance between bone resorption and bone
formation. Both types of bone regeneration, intramembranous and
endochondral in response to fracture healing, are generally known
to have parallels with developmental bone formation, and involve
distinct yet interdependent healing phases consisting of biologically
complex processes regulated by a very large number of transcrip-
tional events[1–3]. Bone marrow ablation in long bones induces
intramembranous bone formation and subsequent bone resorption
in order to regenerate normal bone marrow, and was originally
established as an experimental model to study hematopoiesis[4,5].
Several groups, including ours, have used the rat marrow ablation
model for investigations related to implant fixation[6–12]. The
marrow ablation model has beenutilized further as an experimental
model to study intramembranous bone regeneration with concen-
tration on histological and biochemical approaches and focused
gene expression analysis[2,13–16]. From these investigations, it is
understood that following marrow ablation there are three major
and distinct, yet overlapping, phases of healing which can be
generally described. The first phase primarily consists of clot
formation and inflammation from days 1 to 5. The second major
phase is that of repair from day 3 to 14, and involves
neovascularization, perivascular maturation, mesenchymal stem
cell migration, proliferation and condensation, osteoblastic differ-
entiation, and woven bone formation. Lastly, there is a remodeling
phase from approximately days 10 to 28, until restoration of fatty
and hematopoietic marrow is achieved by 56 days.
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bone remodeling following rat femoral ablation surgery can be
well-defined by histological methods, enhanced understanding of
temporal gene expression profiling and identification of significant
biological pathways associated with the distinct phases of
intramembranous bone regeneration will greatly improve future
advancements of fixation and osteointegration of joint replace-
ment implants[17], design and synthesis of novel biomaterials, and
bone tissue engineering[18].
Therefore, the mechanical ablation of the rat femoral marrow
cavity is an established and suitable model for gene expression
profiling studies regarding intramembranous bone regeneration.
Our group has previously used this rat femoral marrow ablation
model to characterize coexpression patterns of 39 genes during
repair phases of intramembranous bone regeneration up to 14
days[2] and to report modulation of expression of 21 osteogenic
genes following local application of rhTGF-b2[19]. To date, there
have been no published reports of genome-wide temporal
transcriptional analysis of intramembranous bone regeneration
that takes place in a marrow ablation model. A recent report
utilized microarray data and temporal transcriptional profiling
analysis of the mouse transcriptome of an endochondral bone
formation process occurring during a 21 day period of fracture
healing[20]. Certain gene expression data analysis methods used
for that study are similarly used in the present study, including a
Bayesian modeling approach to cluster temporal gene expression
profiles providing by the Cluster Analysis of Gene Expression
Dynamics Program (CAGED), and specific analysis to identify
significant biological processes and pathways using the DAVID
bioinformatics resources. In this study, we identify significant
pathways including matrix metalloproteinases (MMPs), Wnt
signaling, TGF-b signaling, and notch signaling for major
temporal expression groups, as well as differential pathways and
transcription factors expressed at each time point up to 56 days.
Materials and Methods
Rat Model
In an Institutional Animal Care and Use Committee of the
Rush University Medical Center (IACUC; Protocol #06-005)
approved study, 45 adult male rats (Sprague Dawley, 400-425 g)
were divided into nine groups: intact control (0 day), and 1, 3, 5, 7,
10, 14, 28, and 56 days post marrow ablation. Forty animals
received unilateral femoral ablation, adapting the method
described previously[2,14,15]. Briefly, the rats were anesthetized
by intraperitoneal injection of ketamine hydrochloride (100 mg/
kg) and xylazine (5 mg/kg) supplemented as necessary. Surgery
was performed with adherence to aseptic technique. The hindlimb
was shaved and scrubbed with ethanol and betadine solution. An
incision (,1 cm) was made along the medial aspect of the patella,
and the patella along with the quadriceps tendon and patellar
ligament were retracted to expose the distal condyles of the femur.
A 2.0 mm hole was drilled through the patellar surface of the
femur to gain access to the medullary canal. The contents of the
marrow cavity were disrupted mechanically and reamed by hand
with a 2.0 mm drill bit proximally up to the lesser trochanter. The
canal was then irrigated with 10 ml of saline. The distal opening
hole in the bone was sealed with bone wax, the patella was
repositioned, and the deep fascia and skin sutured separately.
Following surgery, the locomotion, grooming, and eating habits of
the surgically treated rats were normal. At each time point,
animals were killed in a carbon dioxide chamber, and whole
femurs were harvested and denuded of soft tissue.
Total RNA Extraction
For three samples per time point, both the distal and proximal
ends of the femurs were cut off in order to exclude the epiphyses
and growth plate regions. Diaphyseal marrow tissue and cells from
the mid-shaft were flushed out using TrizolH. Following homog-
enization, 1 ml of solution was transferred to a 1.5 ml Eppendorf
tube and centrifuged at 12,000 g for 10 minutes at 4uC to remove
insoluble material. The supernatant containing RNA was
collected, mixed with 0.2 ml of chloroform, and centrifuged at
12,000 g for 15 minutes at 4uC. After RNA in the aqueous phase
was transferred into a new tube, the RNA was precipitated by
mixing 0.5 ml of isopropyl alcohol and recovered by centrifuging
the tube at 12,000 g for 10 minutes at 4uC. The RNA pellet was
washed briefly in 1 ml of 75% ethanol and centrifuged at 7,500 g
for 5 minutes at 4uC. Finally, the total RNA pellet was dissolved in
diethylpyrocarbonate (DEPC) water, and its quantity was assessed
by spectrophotometric analysis.
Experimental Design for Gene Expression Profiling
A flow chart displaying the major steps involved in the
experimental design is provided in Figure 1. Gene expression
profiling was performed on total RNA samples that were collected
at day 0, which is the biological reference of intact bone, and at
1, 3, 5, 7, 10, 14, 28, and 56 days post-ablation of rat femoral
marrow.
Microarray Hybridization and Data Acquisition
For each of the three samples per time point, gene expression
was analyzed with GeneChipH Rat Genome 230 2.0 Arrays
(Affymetrix, Santa Clara, CA), which is comprised of over 31,000
probe sets representing approximately 28,700 well-characterized
rat genes. For each gene, eleven pairs of oligonucleotide probes are
synthesized in situ on the arrays. Total RNA from the samples was
hybridized using optimal reagents and standardized protocols, a
GeneChipH Hybridization Oven, a GeneChipH Fluidics Station,
and a GeneChipH Scanner 3000 enabled for High-Resolution
Scanning. Data acquisition from the microarrays also required the
use of Affymetrix GeneChipH Command ConsoleH Software
(AGCC).
Microarray Expression Data Pre-processing
The raw gene expression data from Affymetrix were available in
the form of binary CEL (Affymetrix cell intensity) files. The open-
source integrated software system BRB-ArrayTools (Dr. Richard
Simon and BRB-ArrayTools Development Team) [21] was used
and the CEL files were collated with RMA (robust multi-array
average) [22] method and ‘‘affy’’ R/Bioconductor package to
compute probeset summaries [23]. This utilized a three-step
approach of background correction on PM (Perfect Match) data,
quantile normalization, and Tukey’s median polish algorithm for
summarization of probe level data. The data discussed in this
publication have been deposited in NCBI’s Gene Expression
Omnibus[24] and are accessible through GEO Series accession
number GSE22321 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?token=hbybhuqmksgeydy&acc=GSE22321). Specific genes are
mentioned by the gene name and/or official gene symbol, along with
the Entrez Gene ID number in square brackets.
Microarray Expression Data Analysis
A univariate F-test (with random variance model) with a
significance threshold of p,1610
23 (an appropriately stringent
significant level to reduce the chance of false positives) was
p e r f o r m e dw i t hB R B - A r r a y T o o l sa n du s e dt od e t e r m i n e
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Gene expression profiles were clustered with Cluster Analysis of
Gene Expression Dynamics (CAGED version 1.1) program,
which utilizes a Bayesian model-based clustering method on
temporal gene expression data[25] and uses an agglomerative
procedure to identify the most probable set of clusters, where
genes assigned to certain clusters have similar temporal
expression profiles. In turn, genes clustered together in this
way are likely to share similar physiological functions or
regulation. Data were normalized as ratios to the expression
values on Day 0. A model order of 0 was used, where data from
each time point are assumed to be independent from each other.
T h ep r i o rp r e c i s i o na n dg a m m av a l u ew e r es e tt o1a n d0 ,
respectively, where the prior precision is the size of the sample
upon which the prior distribution is built, while the gamma value
is the rate to zero of the prior precision, with 0 representing the
case ofperfect ignorance. A Bayes Factor of 1 was used to impose
this minimum limit for accepting the merging of two clusters if
the Bayes Factor of their merging is at least the value of 1. The
method required a similarity measure to guide the search
procedure and a Euclidean distance measure between gene
expression profiles was adopted. Goodness of fit of the resulting
model was assessed by checking the normality of the standard-
ized residuals of each cluster.
Each cluster identified by CAGED analysis was assigned to one
of the three major temporal groups according to increased,
variable, or decreased expression, which were then further
analyzed with DAVID EASE (version 2.0)[26] software to identify
significant gene ontology categories or biological pathways. All
significant gene categories associated with the Biological Processes
domain of the Gene Ontology (GO) Consortium[27] were
determined, using a significance threshold of p,0.05. Overall
major categories of biological processes were formed by manually
combining specific subcategory terms having related or overlap-
ping functions. DAVID EASE was also used to analyze the gene
sets for each major temporal group (increased, variable, decreased
expression) to find significant known pathways determined by
KEGG[28] and GenMAPP[29] databases, using a significance
threshold of p,0.05. Cluster 3.0[30] was used to cluster the log
base 2 expression values (for each day time point vs. day 0 time
point) of genes associated with certain significant biological
pathways of interest from the three major temporal expression
groups (increased, variable, and decreased expression). For each
significant pathway identified, the number of significant genes
from the initial significant gene list known to be associated with a
given pathway is noted as ‘‘Gene List Hits’’. Additionally, the total
number of genes on the Affymetrix GeneChipH Rat Genome 230
2.0 Array known to be associated with a given pathway is noted as
‘‘Gene Total Hits’’. The log base 2 fold-change ratios were
clustered using hierarchical clustering with a centered correlation
distance/similarity metric and average linkage clustering method.
The clustered data table file was viewed in TreeView[31] using the
pixel setting contrast default of 3 and using blue and red to
represent positive and negative fold-change expression values,
respectively. A univariate two-sample T-test with significance
threshold of p,1610
23 in BRB-ArrayTools was further used to
determine significant gene lists of gene probe sets differentially
expression on each time point (day 1, 3, 7, 10, 14, 28, and 56 vs.
day 0 intact control) post-ablation. DAVID EASE was used to
analyze gene lists for each time point post-ablation and find all
known pathways determined by KEGG and GenMAPP databases
using a significance threshold of p,0.05. Additionally the total
number of probe sets known to be transcription factors and
present on the GeneChipH Rat Genome 230 2.0 Array was
determined to be 1,254, and significant gene lists for each time
point (each day vs. day 0) were compared with the total number of
transcription factor list, and the number of significant transcription
factors expressed for each time point was found.
Histological methods for imaging of femoral marrow
samples at each post-ablation time point
For two animals per time point, the whole femur was dissected
and fixed in 4% paraformaldehyde in phosphate-buffered saline.
Tissues were decalcified with 0.5 M ethylenediaminetetraacetate
(EDTA) and embedded in paraffin. Four-mm-thick sections were
Figure 1. Flow chart of the chronological steps involved in the
microarray analysis. Each box and corresponding arrow display a
major step in the experimental design and genome-wide analysis using
microarrays and gene expression analysis resources. Programs used for
certain steps of the analysis are bold and underlined.
doi:10.1371/journal.pone.0012987.g001
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hematoxylin and eosin. Images from selected sub-metaphyseal
sites were recorded at 10x and 40x magnification with a
NikonH600L photomicroscope.
Results
Representative histological images of femoral marrow
samples at each time point post-ablation
Stages of bone regeneration in the ablated intramedullary space
are illustrated in Figure 2. This regenerative sequence occurs in
spatially and temporally complex domains within the metaphyseal
and diaphyseal regions. The process can be divided into eight
subphases. Immediately following the ablation, a blood clot fills
the space producing a fibrin and platelet laden substrate for a
succession of cellular infiltrates (clot consolidation phase, days
1–3). The perimeter of this clot shows polymorphonuclear
inflammatory infiltration associated with damaged penetrating
vessels (inflammatory phase, days 3–5). Subsequently, there is a
rapid invasion of fibrovascular progenitors that actively generate a
collagenous matrix within the clot (granulation phase, days 4–7).
Vasculogenesis and angiogenesis become evident in this primitive
matrix structure wherein new capillary networks become con-
nected to feeder vessels to establish a circulation (neovasculariza-
tion phase, days 3–7). Perivascular infiltrates, including pericytes,
lymphocytes, mast, and mononuclear cells become prominent as
this primitive vascular network matures and establishes flow
(perivascular maturation phase, days 5–10). Giant cells become
conspicuous within this perivascular domain. The extravascular
collagenous domains increase in density with sites of mineraliza-
tion characteristic of woven-bone that assumes trabecular form
(osteogenic phase, days 5–10). Arrays of osteoblastic cells begin to
occupy the woven bone surfaces to produce lamellar bone on the
woven bone cores (trabecular maturation phase, days 7–14).
Variable sites of osteoclastic activity accompany this trabecular
maturation phase, finally tipping the balance to the remodeling
and resorption of the intramedullary trabecular structure (resorp-
tion phase, days 10–28) as the fatty and hematopoietic marrow is
reconstituted (marrow reconstitution phase, days 28–56). The
stages represented in the figure are overlapping as new trabecular
bone rapidly forms to occupy the intramedullary space by day 7 to
14 and, following resorption of much of this bone by day 28, the
fatty and hematopoietic marrow composition is restored.
Temporal clusters of expression profiles
The graphical representations of the average expression profiles
for each of the 8 unique temporal clusters determined by cluster
analysis of significant gene probe sets are shown in Figure 3.
These clusters can be differentiated according to the pattern and
Figure 2. In-situ histology of intramedullary bone formation at
each post-ablation time point (10X & 40X). Intact Day 0,
submetaphyseal regions of the intact bone characteristically are
populated by adipocytes and hematopoetic cell populations among
scattered trabecular profiles. Day 1, the post-ablation clot containing
scattered polymophonuclear cells fills the marrow space. Day 3, the
clot is beginning to show cellular infiltration by cells of indeterminate
origin. Day 5, organization of the clot with cell transformations in a
fibrovascular structure with small vessels and an immature collagenous
network. Day 7 and Day 10, increases in collagenous interstitial matrix.
Day 14, consolidation and modeling of pretrabecular matrix structure
with expansion of cellularity in perivascular space of the maturing
vascular network. Day 28 and Day 56, maturation of trabecular
structure and marrow shows reconstitution of the pre-ablation tissue
architecture. Osteocytes and bone-lining osteoblastic cells are evident.
doi:10.1371/journal.pone.0012987.g002
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to the increased expression group (Figure 3A), clusters 2, 5, and 6
were assigned to the variable expression group (Figure 3B), and
clusters 3 and 4 were assigned to the decreased expression group
(Figure 3C). Clusters were assigned to the variable group if the
expression profiles of all genes contained in that cluster exhibited
patterns of both increased and decreased expression temporally
(namely cluster 2 and 5) or if the log base 2 fold-change of
expression values were less than 0.5 for all time points (cluster 6).
Table S1 provides detailed information and expression data
regarding the gene probe sets comprising each of the 8 clusters.
Identification of significant biological process ontologies
and pathways associated with major temporal groups of
clustered gene expression profiles
Pie graphs (Figure 4) present the percentage distribution of
statistically significant (p,0.05) biological process ontologies
identified for increased, decreased, and variable expression groups.
All individual biological ontology results were manually examined
for related or overlapping functions in order for consolidation into
overall major categories of biological process and this detailed
information is summarized and shown for each major temporal
group in Table S2A-D. For all three of the major temporal
groups and therefore during all time points of intramembranous
bone regeneration following marrow ablation, certain biological
processes comprise large percentages out of the total biological
functions identified. These aforementioned biological processes
were specific aspects of metabolism, a large variety of develop-
mental related processes, cell cycle, cellular signaling, as well as a
large category referred to as miscellaneous. In contrast, there are
unique differences in the percentage distributions of specific
biological functions identified in each of the three temporal
expression groups, and these will be described henceforth.
The major biological processes identified exclusively for
increased gene expressions, which all peaked between days 5
and 10 as shown by their average expression profiles (Figure 4A),
consisted of a large variety of processes related to neurogenesis,
skeletogenesis, cell motility, cell adhesion, vasculogenesis, and Wnt
signaling, as supported by detailed information in Tables S2A
Figure 3. Expression profiles of temporal clusters during intramembranous bone regeneration. Clustering of expression profiles of the
9,062 statistically significant gene probe sets by Bayesian modeling produced 8 temporal clusters, which were further grouped into three major
temporal groups of (A) Increased Expression (cluster #1, 7, and 8; graphed as green), (B) Variable Expression (cluster #2, 5, 6; graphed as
blue), and (C) Decreased Expression (cluster #3 and 4; graphed as red). Data is presented as log base 2 fold-change values over the time points of
day 1, 3, 5, 7, 10, 14, 28, and 56 days post-ablation, and is graphed as a solid line. The cluster number and the number of genes for each clustered
gene expression profile graph are denoted in the title. Note that the scale for the vertical axis is not constant.
doi:10.1371/journal.pone.0012987.g003
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group (Figure 4B) were dominated mostly by elements of
metabolism but also processes related to DNA replication,
apoptosis, cytoskeleton, catabolism, DNA transcription, and T-
cell functions.
Likewise, the majority of the biological processes found for the
decreased expression group (Figure 4C) were related to
metabolism and DNA replication, however, other notable
percentage distributions were exclusively identified for hemato-
poiesis and myelopoiesis.
Another more focused method of analysis was performed on the
gene expression data of the three major temporal groups
(increased, variable, and decreased expression). Significant
(p,0.05) known biological pathways determined by KEGG and
GenMAPP databases were identified and are presented in
Table 1. This analysis revealed that certain significant pathways
identified were unique to the gene expressions comprising only one
of the three major temporal groups. Specifically, the increased
expression group exclusively contains genes involved in pathways
for matrix metalloproteinases (MMPs), Wnt signaling, axon
guidance, TGF-b signaling, and inflammation. Contrastingly,
only the variable expression group contains genes associated with
glycolysis and gluconeogenesis, notch Signaling Pathway, natural
killer cell mediated cytotoxicity, and the B cell receptor signaling
pathway, among others. Furthermore, only the decreased
expression group consists of genes involved in heme biosynthesis,
the p53 signaling pathway, and the hematopoietic cell lineage.
Genes associated with significant pathways of interest from the
three major temporal expression groups were hierarchically
clustered based on their expression profiles and are presented as
heat maps (Figure 5) showing fold-change values (vs. day 0 time
point) of log base 2 expression values. Pathways associated with the
increased expression group that are displayed as heat maps
(Figure 5A) include matrix metalloproteinases (MMPs) (MMP),
Wnt signaling pathway, TGF-b signaling pathway, and inflam-
matory pathway. Other pathways associated with the variable or
decreased expression group that are displayed as heat maps are
notch signaling pathway (Figure 5B) and hematopoietic cell
lineage pathway (Figure 5C), respectively.
Identification of significant biological pathways
associated with each time point post-ablation of marrow
As opposed to significant pathways identified to be associated
with the three major temporal groups based on clustering of all
significant genes, significant (p,0.05) biological pathways were
also identified by analyzing the expression of significant genes at
each time point following bone marrow ablation. Pathway results
for significant gene expressions on each day vs. day 0 are shown in
Table 2, Table 3, and Table 4. All days except Day 56 exhibit
the general pathways of ECM-receptor interaction and focal
adhesion as significant in their resulting lists, with the majority of
time points exhibiting other general pathways related to cell
communication or cell cycle. Collectively, the inflammatory
response and blood clotting cascade pathways are shown to be
significant at all time points. Other pathways of interest, such as
those shown in Figure 5 are significantly expressed only at certain
time points. For example, Wnt signaling and matrix metallopro-
teinases (MMPs) were identified to be differential pathways
involved on Days 1 to Day 7, and Day 1 to Day 10, respectively,
post-ablation of bone marrow. Interestingly, axon guidance and
the p53 signaling pathway are found to be significantly expressed
exclusively on Day 10, and the VEGF signaling pathway is
identified as significant uniquely on Day 14.
Identification of significant transcription factors
expressed at each time point post-ablation of marrow
The XY-scatter plot graph (Figure 6) displays the percentage
distribution of significant transcription factors expressed at each
time point, and Table S3 provides the list of Affymetrix
GeneChipH Rat Genome 230 2.0 Array probe set ID and
transcription factor names for each time point. The complete list
of probe sets for transcription factors present on the Affymetrix
GeneChip H Rat Genome 230 2.0 Array was found to be 1,254.
Comparing the significant probe set lists for each time point post-
ablation (each day vs. day 0) with the master list of known
transcription factors, the number of transcription factors (TFs)
expressed at each time point was determined to be: 42 TFs at Day
1, 99 TFs at Day 3, 211 TFs on Day 5, 73 TFs at Day 7, 79 TFs at
Day 10, 8 TFs at Day 14, 23 TFs at Day 28, and 3 TFs on Day 56.
Therefore, the number of significant transcription factors
markedly peaked at 5 days post-ablation, where there was more
than twice the number of transcription factors differentially
expressed compared to any other time point. It is shown in the
graph in Figure 6 that the percentage of transcription factors
significantly expressed on Day 5 out of the total number of
transcription factors (1,254) on the Affymetrix GeneChipH Rat
Genome 230 2.0 Array was roughly 17%.
Discussion
This study was the first to identify significant biological
processes and pathways from genome-wide transcriptional analysis
during all phases of intramembranous bone regeneration following
marrow ablation in a rat model. We used an oligonucelotide
microarray technology, specifically fabricated by Affymetrix for
Rat Genome 230 2.0, and used univariate F-test to determine a list
of 9,062 gene probe sets significantly differentially expressed over
all time points, which is roughly 30% of the 31,042 gene probe sets
present on the total microarray. The time points of days 1, 3, 5, 7,
10, 14, 28, and 56 days post-ablation of marrow were selected
based on knowledge of the complete timeline of all general bone
healing processes involving phases of inflammation, repair and
new bone formation, and remodeling. This timeline is confirmed
by the data presented, implicating that most expression profiles
return to baseline at 56 days, as shown by the average expression
profiles (Figure 3). A Bayesian model-based clustering method
Figure 4. Percentage distribution of significant Gene Ontology/Biological Processes associated with each major group of clustered
gene expression profiles. DAVID EASE (version 2.0) software was used to analyze the gene lists for each major temporal group (increased, variable,
and decreased expression) to find all categories associated with the Biological Processes domain of the Gene Ontology (GO) consortium, using a
significance threshold of p,0.05. Individual gene ontology results with related or overlapping functions were manually combined into overall major
categories. Each biological process category is assigned a distinct color, and consistent colors were used for comparisons of the same biological
process category found for more than one of the three major groups of clustered gene expression profiles/each of the three pie graphs, which
include Increased Expression Group shown in Figure 4A, Variable Expression Group shown in Figure 4B, and Decreased Expression Group shown in
Figure 4C. For example, the major category of ‘‘metabolism’’ is consistently assigned the color red. The number of genes within each of the three
major temporal groups (increased, variable, and decreased expression) that underwent gene ontology/biological process analysis is denoted in the
title of each pie graph.
doi:10.1371/journal.pone.0012987.g004
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Increased Expression Group (2111 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 26 59 3.33610
211
Focal adhesion 43 161 3.43610
29
Cell Communication 23 82 7.92610
26
Matrix Metalloproteinases 8 17 2.36610
25
Cell adhesion molecules (CAMs) 26 111 6.73610
25
Wnt Signaling 8 25 6.07610
24
Colorectal cancer 16 70 2.28610
23
Arginine and proline metabolism 8 24 2.50610
23
Adherens junction 14 62 4.76610
23
Bladder cancer 9 32 4.97610
23
Axon guidance 19 96 5.27610
23
TGF Beta Signaling Pathway (GenMAPP) 7 28 6.66610
23
Inflammatory Response Pathway 6 22 7.71610
23
Alzheimer’s disease 7 25 1.32610
22
TGF-beta signaling pathway (KEGG) 14 70 1.43610
22
Blood Clotting Cascade 3 7 1.64610
22
Orphan GPCRs 3 8 2.46610
22
Basal cell carcinoma 9 42 3.03610
22
Melanogenesis 14 79 3.81610
22
Antigen processing and presentation 11 58 4.05610
22
Variable Expression Group (4373 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
Glycolysis and Gluconeogenesis 16 31 9.96610
25
Notch signaling pathway 18 40 5.05610
24
Pyruvate metabolism 14 28 5.77610
24
Aminosugars metabolism 10 17 7.02610
24
Natural killer cell mediated cytotoxicity 29 81 1.27610
23
Fatty acid synthesis 9 16 1.79610
23
Nicotinate and nicotinamide metabolism 7 11 2.57610
23
Citrate cycle (TCA cycle) 10 20 3.61610
23
Renal cell carcinoma 22 62 5.42610
23
Pancreatic cancer 22 63 6.73610
23
GnRH signaling pathway 26 81 1.16610
22
Fc epsilon RI signaling pathway 22 66 1.23610
22
Gap junction 25 79 1.59610
22
N-Glycan biosynthesis 14 38 1.73610
22
Biosynthesis of steroids 9 21 1.90610
22
Carbon fixation 8 18 2.10610
22
Terpenoid biosynthesis 3 4 3.09610
22
B cell receptor signaling pathway 17 53 3.77610
22
Calcium Channels 5 10 3.79610
22
Glycosaminoglycan degradation 4 7 3.89610
22
Pentose phosphate pathway 7 17 4.68610
22
Decreased Expression Group (2578 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
Cell cycle (KEGG) 38 97 3.47610
213
Cell cycle (GenMAPP) 10 19 5.39610
26
Heme Biosynthesis 5 5 1.36610
25
Eicosanoid Synthesis 6 12 7.49610
24
p53 signaling pathway 14 54 1.90610
23
DNA polymerase 8 23 2.51610
23
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gene expression profiles. The percentage distribution of significant
biological processes (Figure 4 and Table S2A–D) and the
differential biological/signaling pathways (Table 1) identified for
increased, decreased, and variable expression groups serve as a
genome-wide overview of the main biological functions that occur
during marrow ablation-induced intramembranous bone regen-
eration in the rat femur. Additionally, identification of biological
pathways (Table 2, Table 3, and Table 4) and transcription
factors (Figure 6 and Table S3) significantly expressed at each
time point post-ablation provides important insight into the
regulation of intramembranous bone regeneration in a complete
temporal context.
Each of the phases of new bone formation identified in the
histologic analysis generally progress in an ‘‘outside-in’’ fashion
toward the core of the initial clot matrix. Thus, even though
distinct days can be assigned to a given phase, because of the
spatial and temporal heterogeneity inherent in the regenerative
process, almost all stages can be identified in some, albeit limited,
regions of the ablation site in samples recovered between days 7
and 10. This heterogeneity implies that peaks of activity occur
concurrently in different locations and that critical events and
phenotypic transformations reflected in gene expression at these
transformative sites may occupy small footprints in the overall
expression profiles. Alignment of gene expression patterns with the
phases described above (see Results section) in their spatial context
may eventually help identify genes that are critical to bone
regeneration but appear at low levels within the more dominant
spatial domains at any particular time.
Previous studies of gene expression using marrow ablation
models selectively investigated individual or very limited number
of osteogenesis-associated cytokines or growth factors which are
described and summarized in previous publications by our
group[2,19]. Results determined by the present study complement
conclusions highlighted in those previous publications, in that
intramembranous bone regeneration generally relies upon the
control of gene expression for inflammatory cytokines, osteogenic
growth factors, transcription factors, matrix proteins and protein-
ases, and bone remodeling markers.
Focusing on the most differentially expressed genes in Clusters
8, 1, and 7 in Figure 3A (Increased Expression) and Table
S1, several osteoblastic- and osteogenesis-associated genes of
interest[2] are identified including osteopontin (SPP1 in Cluster 8
[25353]), dentin matrix protein 1 (Dmp1 in Cluster 8 [25312]),
osteonectin (also known as Sparc in Cluster 1 [24791]), osteocalcin
(also known as Bglap in Cluster 7 [25295]), collagen type I (Col1a1
[29393] and Col1a2 [84352]) in Cluster 1), alkaline phosphatase
(Alp1 in Cluster 1 [25586]), and periostin (Postn in Cluster 8
[361945]). It is known that periostin has a functional role as a
matricellular protein in a variety of tissue remodeling and wound
repair situations[32], and it has been recently confirmed that
periostin is a novel marker of intramembranous ossification, but
not endochondral ossification, and exhibits upregulated expression
in the fibrous component of fibrous dysplasia, due to its prominent
influence on collagen fibrillogenesis[33]. Many of the aforemen-
tioned osteoblastic-associated genes exhibit peak upregulation at
day 5 or Day 10, which subsequently and, respectively, result in
bone formation observed in the histology tissue by Days 10 and 14
(Figure 2).
Clusters 8, 1, and 7, in Figure 3A (Increased Expression)
and Table S1, also include a number of osteoclastic- and bone
matrix remodeling-associated genes of interest[2], including
TIMP1 (Cluster 8 [116510]), TIMP2 (Cluster 1 [29543]),
MMP2 (Cluster 8 [81686), MMP12 (Cluster 8 [117033]),
MMP13 (Cluster 1 [171052]), MMP14 (also known as MT1-
MMP in Cluster 1 [81707]), MMP16 (Cluster 1 [65205]), MMP23
(Cluster 1 [94339]), cathepsin K (Ctsk in Cluster 8 [29175]),
TRAP5 (Acp5 in Cluster 1 [25732]), osteoprotegerin (Tnfrsf11b in
Cluster 1 [25341]), PTHr1 (Cluster 1 [56813]), and RANK
(Tnfrsf11a in Cluster 7 [498206]). The aforementioned osteoclas-
tic-associated genes exhibit peak upregulation at day 10, which
subsequently result in bone resorption and bone remodeling
observed histologically in the tissue by Day 14 and 28 (Figure 2).
No evidence of chondrogenesis was observed histologically in
the tissue at any time point, and two major chondrogenic marker
genes collagen type II (Col2) and transcription factor Sox9 were
not identified as significantly expressed in our model. Therefore,
true chondrogenesis was not identified in this model. However,
other chondrocytic-related marker genes were found within the
significantly expressed genes in Table S1 and in Figure 3A and
Figure 3B, which include aggrecan (Acan in Cluster 1 [58968]),
versican (Vcan in Clusters 1 and 6 [114122]), and syndecan 3
(Sdc3 in Cluster 6 [116673]), where they exhibit peak upregulation
at day 5 followed by a rather steep decline to return to baseline by
day 14. This is suggestive of a transient existence of chondrogen-
esis. This observation is similar to the one reported by Nah et al
Decreased Expression Group (2578 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
Purine metabolism 21 100 2.92610
23
Porphyrin and chlorophyll metabolism 7 19 3.23610
23
One carbon pool by folate 4 9 1.25610
22
Small ligand GPCRs 4 10 1.65610
22
ABC transporters - General 7 26 2.11610
22
Blood Clotting Cascade 3 7 3.17610
22
Sphingolipid metabolism 6 23 3.71610
22
Glioma 11 55 3.89610
22
Hematopoietic cell lineage 13 70 4.49610
22
Folate biosynthesis 4 13 4.93610
22
Glycosphingolipid biosynthesis - ganglioseries 4 13 4.93610
22
doi:10.1371/journal.pone.0012987.t001
Table 1. Cont.
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intramembranous bone formation in chick embryonic frontal bone
and sternum.
Adipocyte marker genes that are also found to be significantly
expressed (Table S1, Figure 3B and Figure 3C) include Pparg
(in Cluster 2 [25664]), adiponectin (Adipoq in Cluster 2 [246253],
Adipor1 in Cluster 4 [289036], Adipor2 in Cluster 5 [312670]),
and Leptin receptor (Lepr in Clusters 2 and 4 [24536]).
Interestingly, all the expression profiles of Clusters 2, 4, and 5
which contain adipocytic markers display a downregulated
expression profile during day 5 until day 10, which contrasts the
expression profiles of Clusters 8, 1, and 7 which contain
osteoblastic-associated marker genes and which show peak
upregulation during day 5 to day 10. In other words, adipocytic-
associated genes are downregulated while osteoblastic-associated
genes are upregulated. Adipocytic-assocatied genes in Clusters 4
and 5 return to baseline by Day 28, leading to restoration of the
fatty marrow, while adipocyte markers genes contained within
Cluster 2 become upregulated at Day 14 and remain so until
day 56.
One of the major pathways identified in our model to be
significantly expressed in the increased expression group (Table 1),
was the molecular function network of matrix metalloproteinases
(MMPs), which was specifically determined to be significantly
expressed at 1, 3, 5, 7, and 10 days post-ablation (Table 2 and
Table 3). Eight MMP-specific genes with significant increased
expression that were identified using the GenMAPP database were
Bsg, Timp 1, Timp 2, MMP2 (gelatinase A or type IV
collagenase), MMP12 (metalloelastase), MMP13 (collagenase),
MMP14 (membrane-type 1 MMP), and MMP16 (membrane-type
3 MMP), and these are highlighted in the heat map for MMP
genes in Figure 5A. It can be seen that the expression values of
MMP2, MMP14, TIMP2, and MMP16 are hierarchically
clustered together. This result is expected since MMP14 (also
known as MT1-MMP) and TIMP-2 are specifically involved in the
cell surface mechanism to activate proMMP-2[35,36], that
essentially contributes to the promoting the invasive capacity of
tumor cells[35] and mesenchymal stem cells[37], and it is also
known that MMP16 (MT3-MMP) activates MMP2 by cleavage of
proMMP-2[38]. From the results of the temporal expression
profile clustering, the most up-regulated genes were TIMP1,
MMP2, and MMP12 (Cluster 8 in Figure 3A and Table S1).
Other MMPs that exhibited significant increased expression were
TIMP2, MMP13, MMP14, and MMP16 (Cluster 1 in Figure 3A
and Table S1). MMP13, a known collagenase, exhibited
sustained strong induction in our model for up to 14 days post-
ablation, and is known to have important functions in bone
formation and remodeling. It has previously been reported that
MMP13 is specifically required to cleave collagen type II and
aggrecan during the transition from cartilage to bone at the
growth plate during long bone development, in addition to
mediating initial and continual remodeling of trabeculae during
ossification[39,40]. This knowledge correlates with the relationship
of MMP13 and Aggrecan gene expression observed in the data
from our model. Aggrecan was found as a significantly
upregulated gene in our model (Cluster 1 in Figure 3A and
Table S1) with its peak expression at the day 5 and 7 time points.
MMP13 reached peak expression on day 10 and 14, during which
a significant decline towards baseline was seen for Aggrecan
expression. It has also been recently reported, using non-stabilized
or stabilized fracture models in mice, that MMP13 is required for
both endochondral and intramembranous ossification during bone
repair, likely for initial degradation of ECM prior to the invasion
of blood vessels and osteoclasts[41]. These interesting findings
implicate that some extent of transient chondrogenesis is occurring
in our model in addition to the predominant intramembranous
bone regeneration induced by bone marrow ablation, even though
cartilage were not histologically evident. Furthermore, our
previous study demonstrated that a biomimetic polymer hydrogel
with a semi-interpenetrating network that incorporates an
MMP13 degradable crosslinker peptide and an integrin-binding
peptide (containing the RGD domain) implanted in a rat femoral
ablation model leads to significantly enhanced bone regeneration,
likely due to enhanced osteoblast migration and proliferation in
such constructs[18]. Further studies involving tailored design of
biomaterials could benefit from the knowledge presented here
regarding MMP-specific genes to target particular MMP-related
peptide sequences for certain types of tissue regeneration.
Another key pathway identified to be significantly expressed in
the increased expression group (Table 1) was the cellular process
pathway of Wnt signaling, which was found to be significantly
expressed at the study timepoints of 1, 3, 5, and 7 days post-
ablation. A study by Kim et al. used a model where bone
regeneration in a 1.0-mm monocortical tibial defect occurs
exclusively through intramembranous ossification, and they
reported that Wnt signaling is upregulated at the injury site,
thereby prompting marrow-derived osteoprogenitor cells to
proliferate and mediating subsequent osteoblast differentia-
tion[42]. In our model, Wnt signaling related genes for Wnt5a
[64566], Fzd1[58868], Fzd2 [64512], Prkch [81749], and Ctnnb1
(b-catenin [84353]), as well as transcriptional activation genes for
Ccnd1 [58919], Jun [24516], and Plau [25619], were found to be
significantly upregulated as identified by the GenMAPP database,
and are highlighted in the heatmap for Wnt signaling genes in
Figure 5A (and are also found in Cluster 7 in Figure 3A and
Table S1). In the previously mentioned study by Kim et al., Wnt5a
was also identified as significantly expressed in all domains of the
injury site in their primarily intramembranous ossification model,
which included the osteocytes, endosteum, bone marrow, growth
plate, and the periosteum, which was the only domain adjacent to
Figure 5. Clustered heat maps of genes involved in significant pathways identified for each major group of clustered gene
expression profiles. Cluster 3.0 was used to cluster the log base 2 fold-change expression values (vs. day 0 time point) of genes associated with
certain significant biological pathways of interest from the three major temporal expression groupings (increased, decreased, and variable
expression). Pathways of interest from the Increased Expression Group include those for matrix metalloproteinases (MMPs) (GenMAPP), Wnt signaling
(GenMAPP), TGF-b signaling (KEGG and GenMAPP), and inflammatory response pathway (GenMAPP) shown in Figure 5A. A pathway of interest from
the Variable Expression Group is notch Signaling Pathway (KEGG) shown in Figure 5B, and a pathway of interest from the Decreased Expression
Group is hematopoietic cell lineage (KEGG) shown in Figure 5C. The log base 2 fold-change ratios were clustered using hierarchical clustering with a
centered correlation distance/similarity metric and average linkage clustering method. The clustered data table file was viewed in TreeView using the
pixel setting contrast default of 3 and using blue and red to represent positive and negative fold-change expression values, respectively. The resulting
clustered heat maps display the fold-change (vs. day 0 time-point) expression values for each gene in the rows, and for each time point in the
columns, and the order of the rows is based on the result of clustering genes of similar profiles. Each heat map displays the total list of genes on the
Affymetrix GeneChipH Rat Genome 230 2.0 Array that are associated with the particular pathway of interest. Genes from the initial significant gene list
of 9,062 (and noted as ‘‘Gene List Hits’’ in Table 1) associated with each pathway are highlighted with a bold green font for their gene symbols on the
right side of the heat maps.
doi:10.1371/journal.pone.0012987.g005
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Day 1 vs Day 0 (1163 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 20 59 3.17610
210
Focal adhesion 24 161 1.08610
24
Cell Communication 15 82 2.42610
24
Inflammatory Response Pathway 7 22 1.02610
23
Glycolysis and Gluconeogenesis 8 31 2.01610
23
Small cell lung cancer 11 69 5.11610
23
Glycolysis/Gluconeogenesis 8 42 5.50610
23
Hematopoietic cell lineage 11 70 5.71610
23
Cell adhesion molecules (CAMs) 15 111 5.87610
23
Cytokine-cytokine receptor interaction 16 129 1.03610
22
Renal cell carcinoma 9 62 1.98610
22
Nucleotide sugars metabolism 2 4 2.42610
22
ABC transporters - General 5 26 2.58610
22
Prion disease 3 11 3.21610
22
Porphyrin and chlorophyll metabolism 4 19 3.34610
22
Matrix Metalloproteinases 4 17 4.15610
22
Wnt Signaling 5 25 4.40610
22
Ether lipid metabolism 4 21 4.65610
22
Day 3 vs Day 0 (2670 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 26 59 5.97610
29
Focal adhesion 46 161 1.63610
27
Matrix Metalloproteinases 9 17 4.54610
25
Cell Communication 24 82 1.14610
24
Heme Biosynthesis 4 5 9.77610
24
Cell adhesion molecules (CAMs) 27 111 1.18610
23
Wnt Signaling 9 25 1.64610
23
Arginine and proline metabolism 9 24 2.69610
23
Inflammatory Response Pathway 8 22 2.84610
23
Small cell lung cancer 18 69 3.43610
23
Cell cycle 23 97 3.82610
23
Colorectal cancer 18 70 4.06610
23
Adherens junction 16 62 6.36610
23
Porphyrin and chlorophyll metabolism 7 19 8.96610
23
Aminosugars metabolism 6 17 1.93610
22
Bladder cancer 9 32 2.15610
22
Carbon fixation 6 18 2.57610
22
Glycolysis and Gluconeogenesis 8 31 2.73610
22
Glycan structures - biosynthesis 2 11 46 3.76610
22
Alzheimer’s disease 7 25 4.18610
22
Hematopoietic cell lineage 15 70 4.22610
22
Blood Clotting Cascade 3 7 4.37610
22
Glycolysis/Gluconeogenesis 10 42 4.766 610
22
Day 5 vs Day 0 (5823 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 34 59 5.52610
27
Cell cycle 44 97 6.09610
25
Focal adhesion 65 161 1.06610
24
Cell cycle 12 19 4.12610
24
Heme Biosynthesis 5 5 9.54610
24
Blood Clotting Cascade 6 7 1.30610
23
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response[42].
The present results with marrow ablation-induced intramem-
branous bone regeneration share similarities with two other
microarray studies using rat closed fracture models, which also
identified genes for Wnt5a, Frizzled 2, and b-catenin[1,43]. In the
study by Hadjiargyrou et al., the identified temporal expression for
Wnt5a was interestingly reported to increase at day 3 post-
fracture, then decline at days 5–7, then return to an increased
expression at 10–14 days, and finally drop back down to baseline
levels by 21 days[1]. A similar but more early and transient
temporal expression profile for Wnt5a was found in our model,
with an increase at day 1 post-ablation, then a decrease on day 3,
then a marked increase at day 5, then another decrease at days 7
and 10, followed by a further decrease towards baseline by 14
days. Wnt5a is known as a non-canonical Wnt ligand that signals
independent of b-catenin through the Wnt/Ca
2+ pathway, which
not only regulates Ca
2+ flux and Ca
2+-sensitive protein kinases and
transcription factors, but can inhibit the canonical Wnt pathway
by promoting degradation of b-catenin[44]. Specific mechanisms
involved with the regulation of bone regeneration by non-
canonical Wnt pathway are still relatively unknown, but several
studies have shown evidence supporting the role of Wnt5a in the
early stages of fracture repair, namely inflammation and
chondrogenesis[1,44]. Additionally, there is other evidence that
Wnt5a induces osteoblastogenesis by reducing PPARc-induced
adipogenesis in bone marrow mesenchymal stem cells[45].
Considering this knowledge of Wnt5A, in addition to the
information previously discussed regarding MMP13, it is possible
that early and transient chondrogenesis may be occurring in our
predominantly intramembranous regeneration model induced by
marrow ablation. Altogether, these intriguing findings from our
study and many other reports implicate that Wnt signaling in bone
repair models, fracture or marrow ablation, is highly intricate and
currently not well understood, evidently involving the activation of
both canonical and non-canonical Wnt signaling pathways[44,46].
It is generally known during the early bone repair phase that
mesenchymal stem cells (MSCs) migrate, proliferate, and undergo
differentiation towards the osteoblastic lineage. It is of interest to
further investigate signaling pathways and genes expressed by
MSCs during this phase for overall enhancement and acceleration
of bone regeneration following injury and surgery, and the
temporal transcriptional profiling data results presented here are
expected to aid in that research. Signaling pathways known to be
in involved in the self-renewal and osteogenic differentiation of
MSCs are Wnt signaling, BMP/TGF-b signaling, and notch
signaling[47], which are pathways identified in this study to be
significantly expressed within the increased or variable expression
groups, respectively. There is evidence that MSCs express Wnt2,
Wnt4, Wnt5a, Wnt11, Wnt16, Fzd2, Fzd3, Fzd4, Fzd5, Fzd6, and
Dkk1[48], and that canonical Wnt3a increases levels of b-catenin
and the proliferation rate while noncanonical Wnt5a impedes the
process of chondrogenesis[47]. Indeed, there is cross-talk between
canonical and noncanonical Wnt signaling in MSCs, as canonical
Wnt3a suppresses Wnt5a to maintain MSC in an undifferentiated
and self-renewing state, while noncanonical Wnt5a inhibits Wnt3a
in order to mediate enhancement of osteogenic differentiation of
MSCs[49,50]. Specifically, Wnt5a suppresses b-catenin/TCF
signaling to decrease the level of cyclin D1 and proliferation rate
of MSCs[49,51].
The notch signaling pathway is thought to be involved in
osteoblastogenesis and skeletogenesis but its particular role is not
well understood[47]. It has been reported that within the bone
marrow, notch signaling suppresses osteoblastic differentiation and
the Wnt/b-catenin signaling pathway generally acts to maintain a
pool of proliferating mesenchymal progenitors[52,53]. Although
not specifically identified as significant by the KEGG database
through DAVID EASE, genes involved in the notch Signaling
Pathway and differentially expressed over all time points in our
model, include Hes1 [29577], Jag1 [29146], and Numbl [292732].
It was recently confirmed that Hes1 plays an important role in
mediating the inhibition of osteoblastogenesis and the Wnt/b-
catenin pathway by intracellular domains of notch signaling, likely
by preventing the interaction of b-catenin with the transcriptional
co-repressor Groucho/TLE and LEF-1[53]. The notch ligand
gene Jag1 is known as an evolutionarily conserved target of the
canonical Wnt signaling pathway and is a key molecule for
induction of self-renewal and maintenance of homeostasis of stem
and progenitor cells[54], while Numb and Numbl induce
differentiation by inhibiting notch signaling in progenitor cells[55].
Regarding the TGF-b signaling pathway, many significantly
expressed genes were identified by the KEGG or GenMAPP
databases and are shown as three major clusters in the TGF-b
signaling pathway heat map in Figure 5A.O n en o t a b l ec l u s t e r
Day 5 vs Day 0 (5823 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
Matrix Metalloproteinases 10 17 2.83610
23
Arginine and proline metabolism 13 24 4.24610
23
Aminosugars metabolism 10 17 5.57610
23
p53 signaling pathway 23 54 9.05610
23
Carbon fixation 10 18 9.54610
23
Gap junction 31 79 1.11610
22
Glioma 23 55 1.17610
22
Adherens junction 25 62 1.48610
22
Porphyrin and chlorophyll metabolism 10 19 1.53610
22
Colorectal cancer 27 70 2.18610
22
Wnt Signaling 11 25 2.80610
22
Hematopoietic cell lineage 26 70 3.91610
22
doi:10.1371/journal.pone.0012987.t002
Table 2. Cont.
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[29139], Id3 [25585], Spp1 (osteopontin [25353]), Stat3 [25125],
Ctnnb1[84353],and Rock2 [25537].Interestingly,ithasbeenshown
with mouse embryonic cells that Id proteins, such as Id3, in
c o n j u n c t i o nw i t hS T A T 3s u s t a i ns t e mc e l ls e l f - r e n e w a la n di n h i b i t
differentiation[56]. Id3 is a significant transcription factor in our data
and can be seen listed for Days 3, 5, 7, and 10 post-ablation in Table
S3. Another cluster of TGF-b related genes consists of Inhbb
[25196], Serpine1 [24617], and Jun [24516], and a third major
cluster contains Tgfbr1 [29591], Tgfb3 [25717], Thbs2 [292406],
Tgfb2 [81809], and Fkbp1a [25639]. It is well accepted that BMP
signaling has an important role in osteoblastogenesis, and TGF-bs
can have both positive and negative effects on osteoblast differenti-
ation. It has been shown that bone formation is induced by injecting
TGF-b into periosteum, but on the other hand, an osteoporotic
phenotype resulted with an overexpression of TGF-b2 [ 4 7 ] .I n d e e d ,i t
has been shown previously by our group and others that
intramembranous bone formation associated with implant fixation
is enhanced following local delivery of TGF-b[11,57–59]. Interest-
ingly, in our data Thbs2, which is clustered with TGF-b2, is highly
expressed from day 3 to day 10 post-ablation, and has been described
as an autocrine inhibitor of proliferation secreted by MSCs[60] and
an important regulator, along with osteonectin (also known as Sparc),
of the osteoblast lineage and bone remodeling[61].
Table 3. Significant biological pathways identified at day 7 and 10 (vs. day 0) post-ablation.
Day 7 vs Day 0 (2205 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 32 59 4.39610
216
Focal adhesion 45 161 2.13610
29
Cell Communication 24 82 6.43610
26
Matrix Metalloproteinases 8 17 2.04610
24
Blood Clotting Cascade 5 7 2.95610
24
Cell adhesion molecules (CAMs) 24 111 1.15610
23
Complement and coagulation cascades 14 53 1.75610
23
Wnt Signaling 8 25 4.22610
23
Colorectal cancer 16 70 4.23610
23
Gap junction 17 79 6.23610
23
Eicosanoid Synthesis 5 12 7.00610
23
Bladder cancer 9 32 7.41610
23
Inflammatory Response Pathway 7 22 7.80610
23
Melanoma 14 64 1.09610
22
Small cell lung cancer 14 69 2.07610
22
Glycosphingolipid biosynthesis - neo-lactoseries 5 15 2.11610
22
Adherens junction 12 62 4.32610
22
Day 10 vs Day 0 (2190 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 27 59 2.43610
212
Focal adhesion 44 161 4.23610
210
Matrix Metalloproteinases 9 17 3.05610
26
Cell adhesion molecules (CAMs) 24 111 3.23610
24
Cell Communication 19 82 5.51610
24
Axon guidance 21 96 6.50610
24
Cell cycle 20 97 1.90610
23
Glycosaminoglycan degradation 4 7 3.16610
23
Bladder cancer 9 32 4.19610
23
p53 signaling pathway 12 54 8.18610
23
Adherens junction 13 62 9.97610
23
Gap junction 15 79 1.47610
22
Blood Clotting Cascade 3 7 1.90610
22
Glioma 11 55 2.41610
22
Colorectal cancer 13 70 2.65610
22
Leukocyte transendothelial migration 17 100 2.76610
22
Orphan GPCRs 3 8 2.84610
22
Melanoma 12 64 3.03610
22
Inflammatory Response Pathway 5 22 4.04610
22
doi:10.1371/journal.pone.0012987.t003
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transcriptional profiling of mouse and human MSCs and the
identification of differentially expressed genes and path-
ways[62,63]. Specifically it was reported that transcripts uniquely
expressed by murine bone marrow-derived MSCs are mostly
transcription factors and genes downstream of the Wnt signaling
pathway and also MSCs exhibit a unique therapeutic effect on T
cells by preventing their proliferation and supporting their
survival[62]. Another study performed microarray-based ge-
nome-wide differential gene expression analysis to identify the
20 most significantly expressed genes in human bone marrow-
derived MSCs, including several we have identified as differen-
tially expressed in our model of intramembranous bone regener-
ation such as Periostin (Postn [361945]), Col3a1 [84032], Col6a3
Table 4. Significant biological pathways identified at day 14, 28, and 56 (vs. day 0) post-ablation.
Day 14 vs Day 0 (459 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
Focal adhesion 18 161 6.75610
27
ECM-receptor interaction 9 59 4.73610
25
Long-term depression 8 68 7.99610
24
Thyroid cancer 5 27 1.03610
23
Blood Clotting Cascade 3 7 1.66610
23
Glycan structures - degradation 3 14 7.43610
23
Leukocyte transendothelial migration 8 100 9.20610
23
Adherens junction 6 62 9.72610
23
Endometrial cancer 5 45 1.02610
22
Bladder cancer 4 32 1.42610
22
Glycosaminoglycan degradation 2 7 1.69610
22
MAPK Cascade 3 15 1.75610
22
Tight junction 8 115 2.03610
22
ErbB signaling pathway 6 75 2.34610
22
Dorso-ventral axis formation 3 22 2.65610
22
Glycosphingolipid biosynthesis - globoseries 2 9 2.78610
22
N-Glycan degradation 2 9 2.78610
22
Melanogenesis 6 79 2.93610
22
GnRH signaling pathway 6 81 3.27610
22
VEGF signaling pathway 5 61 3.42610
22
Cell Communication 6 82 3.44610
22
Renal cell carcinoma 5 62 3.64610
22
Nicotinate and nicotinamide metabolism 2 11 4.09610
22
alpha-Linolenic acid metabolism 2 11 4.09610
22
Fc epsilon RI signaling pathway 5 66 4.58610
22
Day 28 vs Day 0 (532 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
ECM-receptor interaction 13 59 2.17610
28
Focal adhesion 16 161 3.89610
25
Cell Communication 10 82 2.38610
24
Hematopoietic cell lineage 9 70 3.32610
24
Inflammatory Response Pathway 4 22 8.20610
23
Fatty acid biosynthesis 2 5 9.67610
23
Glyoxylate and dicarboxylate metabolism 2 7 1.95610
22
Fatty acid synthesis 3 16 2.10610
22
Reductive carboxylate cycle (CO2 fixation) 2 8 2.54610
22
Blood Clotting Cascade 2 7 2.72610
22
Day 56 vs Day 0 (100 genes) Gene List Hits Gene Total Hits Fisher Exact p-value
Glycosphingolipid biosynthesis - lactoseries 1 7 4.12610
22
Antigen processing and presentation 2 58 4.60610
22
Cholesterol biosynthesis 1 10 4.61610
22
Sulfur metabolism 1 8 4.70610
22
doi:10.1371/journal.pone.0012987.t004
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Table S1), and Col1a1 [29393], Ctgf [64032], Col1a2 [84352],
Serpine1 [24617], Kdelr3 [315131] (Cluster 1 in Table S1)[63].
There are many noteworthy similarities and differences of the
genome-wide transcriptional analysis results presented here for
intramembranous bone regeneration induced by a marrow
ablation model with results previously reported by Bais et al.
regarding the endochondral bone formation process in fracture
healing [20]. In their paper, it was reported that a little over one-
half of the genes expressed in the mouse genome were
differentially regulated during fracture healing[20]. Our data
indicates that roughly one-third of the genes expressed on the
Affymetrix GeneChipH Rat Genome 230 2.0 Array were
differentially expressed during intramembranous bone regenera-
tion and healing following marrow ablation. Interestingly, many
commonalities can be seen when comparing gene ontology/
biological process analysis of the three major temporal expression
groups (up, variable, and down) from Bais et al. with the results
presented here. Specifically, the many biological process that share
similar percentage distributions for the up or increased expression
group identified in both studies are cell adhesion, cell cycle,
cytoskeleton/actin, development, immune response, ion transport,
many aspects of metabolism, motility, neurogenesis, a variety of
cellular signaling including Wnt (see Table S2A–D from this
study and Table S1 from Bais et al.), and vasculogenesis[20].
Marked differences include that a greater percentage distribution
(7.7%) for skeletogenesis is found from our increased expression
group data for intramembranous bone regeneration model
compared to a much lower value (1%) for skeletogenesis shown
in the increased expression group in Bais et al. which uses a
fracture healing model[20]. Other similarities and differences can
be observed by comparing and contrasting the biological process
percentage distribution for the variable (Figure 4B) and
decreased (Figure 4C) expression groups from this study with
the variable and down groups in Bais et al.[20].
More similarities exist with our results of significant biological
pathways identified (from KEGG and GenMAPP databases) for
each of the three major temporal groups (Table 1) when
compared to pathways identified (by KEGG database) for the
three major temporal groups in Bais et al.[20]. The increased
expression groups in both studies showed significant association
with ECM-receptor interaction, focal adhesion, axon guidance,
focal adhesion, TGF-b signaling, cell communication, adherens
junction, basal cell carcinoma, and Wnt signaling. The same
pathways identified for variable group and the variable group in
Bais et al. include B cell receptor signaling pathway and natural
killer cell mediated cytotoxicity, and the same pathways identified
for the decreased expression groups in both studies include cell
cycle (negative regulators), hematopoietic cell lineage, ABC
transporters (general), and porphyrin and chlorophyll metabo-
lism[20]. Comparing these results from our intramembranous
bone regeneration model and previously reported results from a
fracture healing model implicate many similarities regarding
significant biological processes and pathways during bone repair.
Given the result from this study that roughly 30% of the rat
genome was significantly expressed during all time points of
marrow ablation-induced intramembranous bone regeneration, it
is of interest to discuss what fraction of the genome is involved in
other forms of wound and tissue repair. Similar to bone, the liver
has the ability to regenerate and repair with no resulting scar
tissue. A genome-wide expression study using a rat liver
regeneration model, in which a partial hepatectomy was
performed recently reported that approximately 5.4% of the rat
genome was differentially regulated during rat liver regenera-
tion[64]. Similar to the regeneration of bone, liver regeneration
involves a coordinated cascades of biological events, although our
data confirms that intramembranous bone regeneration involves a
much greater number of significantly activated/expressed genes
compared to liver regeneration. A very recent publication using a
human genome-wide microarray analysis with a cutaneous wound
healing model of thermally injured skin determined that
approximately 4.4% of the human genome was significantly
expressed during a 18-day healing period[65]. It is known that
unlike bone repair, skin repair results in scarring. Interestingly in
their study, osteopontin (also known as SPP1), was highly up-
regulated in the first 17 days and was significantly expressed in our
intramembranous bone regeneration model (see Cluster 8 in
Figure 3 and Table S1 and the heatmap for TGF-beta signaling
genes in Figure 5A). The significant expression of osteopontin in
wound healing supports the knowledge that it is has a broad yet
critical role in injury site extracellular microenvironments
containing highly proliferative cells and undergoing rapid
remodeling. Another study using a rat genome-wide microarray
analysis with an injured spinal cord model found that during a 90
day post-injury period, approximately 15% of the rat genome was
significantly expressed[66]. It was also noted that the overall
expression profiles of significantly increased tissue repair genes and
the timing and sequence of post-spinal cord injury gene expression
resemble the phases known for cutaneous wound healing[66]. The
remarkable ability of bone to repair, such as our model of
intramembranous bone regeneration, appears to involve a much
larger set of significant genes comprising a substantially greater
percentage of the genome than other forms of wound repair.
Supporting Information
Table S1 Tabular summary of the significantly expressed genes
of intramembranous bone regeneration across the time points of
this study. Expressed genes sets are arranged by the numeric
Figure 6. Percentage distribution of significant transcription
factors expressed on each time point (each day vs. day 0) post-
ablation. The total number of probe sets for transcription factors
known to be present on the Affymetrix GeneChipH Rat Genome 230 2.0
Array was determined to be 1,254. Significant probe set lists for each
time point (each day vs. day 0) were compared with the transcription
factors list, and the number of significant transcription factors
expressed for each time point was found. The percentage of the
transcription factors expressed was calculated and graphed for each
time point.
doi:10.1371/journal.pone.0012987.g006
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Gene symbol, gene name, probe set ID on the Affymetrix
GeneChipH Rat Genome 230 2.0 Array, RGD Accessions, Entrez
Gene ID (Rattus norvegicus), and Unigene clusters (Rattus norvegicus)
are denoted. For each gene probe set, log base 2 expression values
for each time point (Day 0, 1, 3, 5, 7, 10, 14, 28, and 56) are
presented, as well as the fold-change expression values for each
day vs. day 0.
Found at: doi:10.1371/journal.pone.0012987.s001 (3.09 MB
XLSX)
Table S2 Identified significant (p,0.05) biological process
ontologies for clustered gene expressions in each of the three
major temporal groups during intramembranous bone regenera-
tion. Table S2A presents the major categories of biological
processes and their percentage distributions, which were deter-
mined by consolidating overlapping or related individual subcat-
egories, and are presented in the pie graphs in Figure 4 for each of
the three major temporal expression groups (increased, variable,
and decreased). Table S2B, S2C, and S2D present all the
individual subcategory terms of biological process ontology results,
the p-value for each, and major category that each was grouped
into for the increased expression group, variable expression group,
and decreased expression group, respectively.
Found at: doi:10.1371/journal.pone.0012987.s002 (0.05 MB
XLSX)
Table S3 Significant gene probe sets known to be transcription
factors expressed on each time point post-ablation (each day vs.
day 0) that were determined and presented in Figure 6. For the
transcription list on each time point, the Affymetrix probe set ID,
gene symbol, and p-value are provided, and the genes are listed in
the order of p-value significance.
Found at: doi:10.1371/journal.pone.0012987.s003 (0.03 MB
XLSX)
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